Glad to see the NY Times, Time Magazine and other major news outlets are reporting on the study showing that interferon does not change disease progression--"Relapses and brain lesions do not, apparently, drive disability, Dr. Tremlett said.

“There may be other processes at work,” she added. “In an ideal world, we want drugs that target whatever is driving long-term disability. We need other drugs aiming at other targets in the brain.” How about looking at cerebral perfusion, Dr. Tremlett?


Multiple Sclerosis Drug Doesn’t Stop Disability, Study Finds
www.nytimes.com
Interferon beta, the most commonly prescribed drug to treat M.S., helps reduce the development of brain lesions and limit the frequency of relapses.